BRIACELL THERAP Shareholders Equity per Share

Shareholders Equity per Share of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity per Share for the quarter ending October 31, 2022 was 0.66 (a -0.53% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity per Share decreased by -77.91%
  • Annual Shareholders Equity per Share for 2022 was 0.67 (a -89.11% decrease from previous year)
  • Annual Shareholders Equity per Share for 2021 was 6.12 (a -221.5% decrease from previous year)
  • Annual Shareholders Equity per Share for 2020 was -5.04 (a 357.02% increase from previous year)
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity per Share of BRIACELL THERAP

Most recent Shareholders Equity per Shareof BCTX including historical data for past 10 years.

Interactive Chart of Shareholders Equity per Share of BRIACELL THERAP

BRIACELL THERAP Shareholders Equity per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.66 0.67 3.0 3.0 0.67
2021 3.63 6.12 2.91 -4.67 6.12
2020 -4.38 -5.04 -3.85 -3.15 -5.04
2019 -353.0 -1.11 1.17 -1.17 -1.1
2018 0.69 2.74 5.69 1.24 2.26
2017 2.76 -4.21 4.76 4.05 2.1
2016 5.41 -5.52 3.89 1.9 2.72
2015 3.1 -9.83 5.37 8.99 5.08
2014 3.5 -8.0 42.14 46.23 4.01
2013 48.3 -99.36 50.39 52.41 50.1
2012 52.98 -106.87 56.1 52.67

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology